Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: sulfa (sulfonamide antibiotics) attending: chief complaint: transfer for ercp major surgical or invasive procedure: ercp with sphincterotomy and stent history of present illness: 62 yo female w/ pmh sig for metastatic ovarian cancer diagnosed 10 years ago, s/p tah and bso, adjuvant chemo (last treated ), and peritoneal stripping in , htn, hyperlipidemia, who presented initially to with malasie and transferred to for ercp. history is taken from chart review and sister. she initially presented to beginning of and was diagnosed w/ an sbo and chronic cholecystitis discharged home on cipro. she represented to the osh with left flank pain, poor appetite, nausea and emesis. per sister, + constipation, infrequent on/off emesis one episode bloody, no fevers/chills, ~100lb weight loss over one year. no shortness of breath/chest pain. . an abdominal us was sig for contracted gallbladder w/ wall thickening, sludge concerning for acute cholecystitis superimposed on chronic inflammatory changes, with mildly dilated cbd 9mm, and loculated ascites. mrcp was notable for dilatation of intrahepatic bile ducts and proximal cbd, with midportion of the cmb narrowed by extrinsic mass. she was guaic neg. labs sig for wbc 11, h/h 13.4/40.7, ast 306, alt 144, t bili 3.8, ap 776, lipase 215. urine cx grew enterococcus faecium (prior urine cx sig for enteroccocus r to amp/vanc/macrobid, s linezolid/gent) and she was started on linezolid. she was transferred to for ercp. labs on transfer sig for down trending ast/alt 127/94, ap 585, but persistently elevated t bili 3.9. . ercp was notable stricture at the common hepatic duct and bifurcation of main biliary duct w/ mild post-obstructive dilation compatible w/ extrinsic compression. a sphincterotomy was performed and biliary stent placed. she had brief episode of sbp in 90s, received 100mcg of neo. during procedure, patient had retained food in the stomach and with worry for aspiration in setting of possible sbo, she remained intubated. . currently, patient is intubated and sedated. . review of sytems: unable to assess past medical history: -- metastatic ovarian cancer: s/p tah/bso, peritoneal stripping -- hypertension -- hyperlipidemia social history: lives with her mother, in . self ambulates. retired, worked for state in public relations. no etoh/cig/illicits family history: no family hx of breast or ovarian cancer. cousin with lymphoma. father ami at 47yo. sister w/ htn. physical exam: general: sedated, intubated, no jaundice heent: sclera mildly icteric, dry mmm, oropharynx clear neck: supple, jvp not elevated, no lad lungs: anterior breath sounds clear to auscultation bilaterally, no wheezes, rales, ronchi cv: regular rate, normal s1 + s2, no murmurs, rubs, gallops abdomen: obese, non-tender, non-distended, bowel sounds present, areas of firmness along lower quadrants, no rebound tenderness or guarding, no organomegaly gu: foley in place ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema pertinent results: 09:23pm urine comment-due to abnormal urine color intrepret dipstick with caution 09:23pm urine rbc-2 wbc-2 bacteria-few yeast-none epi-2 09:23pm urine color-brown appear-cloudy sp -1.025 11:11pm pt-14.1* ptt-30.8 inr(pt)-1.2* 11:11pm plt count-248 11:11pm wbc-9.4 rbc-4.70 hgb-12.1 hct-38.7 mcv-82 mch-25.8* mchc-31.3 rdw-17.2* 11:11pm calcium-8.8 phosphate-4.4 magnesium-1.4* 11:11pm alt(sgpt)-80* ast(sgot)-77* ld(ldh)-307* alk phos-592* tot bili-2.8* 11:11pm estgfr-using this 11:11pm glucose-165* urea n-7 creat-0.6 sodium-137 potassium-3.3 chloride-100 total co2-28 anion gap-12 . ercp : findings: esophagus: limited exam of the esophagus was normal stomach: limited exam of the stomach was normal duodenum: limited exam of the duodenum was normal major papilla: normal major papilla cannulation: cannulation of the biliary duct was successful and deep with a sphincterotome after a guidewire was placed. contrast medium was injected resulting in complete opacification. biliary tree: a single stricture of malignant appearance that was 40 mm long was seen at the common hepatic duct and bifurcation of the main biliary duct. there was mild post-obstructive dilation. these findings are compatible with extrinsic compression.likely large mass at porta hepatis causing bismuth iii type stricture. unable to access left system. right system appears moderately dilated procedures: a sphincterotomy was performed in the 12 o'clock position using a sphincterotome over an existing guidewire. a 6cm by 80mm uncovered wallflex biliary stent biliary stent was placed successfully. area of stricture bridged successfully. distal end of stent within cbd. impression: cannulation of the biliary duct was successful. a single stricture of malignant appearance that was 40 mm long was seen at the common hepatic duct and bifurcation of the main biliary duct. there was mild post-obstructive dilation. these findings are compatible with extrinsic compression. likely large mass at porta hepatis causing bismuth iii type stricture. unable to access left system. right system appears moderately dilated a sphincterotomy was performed in the 12 o'clock position using a sphincterotome over an existing guidewire. a 6cm by 80mm uncovered wallflex biliary stent biliary stent was placed successfully. area of stricture bridged successfully. distal end of stent within cbd. . cxr in comparison with study of , allowing for differences in patient position, there is little change. left basilar opacification persists, consistent with volume loss and pleural effusion. diffuse pulmonary metastases are again seen. ct torso w/contrast: 1. mid-small bowel obstruction, likely due to omental and anterior abdominal wall mass. 2. necrotic left pelvic side-wall mass, possibly nodal. 3. enlarged celiac axis, paraaortic, and right external illiac lymph nodes. 4. innumerable bilateral pulmonary nodules compatible with metastatic disease. 5. bilateral pleural effusions, left greater than right with compressive atelectasis on the left side. 6. stent within the cbd, but the distal tip does not difinitely enter into the duodenum. there is periportal edema and mild biliary ductal dilation. . microbiolgy: c diff neg x 3, most recent from . sputum culture gram stain (final ): >25 pmns and >10 epithelial cells/100x field. gram stain indicates extensive contamination with upper respiratory secretions. bacterial culture results are invalid. blood culture ngtd . discharge labs: 04:04am wbc 6.5 hgb 9.4* hct 27.7* mcv 80* plts 210 inr 1.3 glucose 132* bun 5* cr 0.4 na 131* k 3.8 cl 97 co2 30 mg 2.0, ca 7.9, phos 3.2 alt 15, ast 15, alk phos 200, t bili1.0 brief hospital course: cholecystitis: mrcp notable for extrinsic mass w/ dilatation of cbd and hepatic duct. no evidence for cholangitis. patient is currently s/p ercp that was notable for stricture at the common hepatic duct and biliary duct. sphincterotomy and stenting was performed. her lfts continued to improve and she remained hemodynamically stable. . sbo: suspected sbo, given high grade emesis, abdominal pain and distension and from residual food seen in stomach during procedure. likely secondary to presumed extensive peritoneal involvement of her ovarian cancer. ct torso was done which confirmed incomplete partial small bowel obstruction of small and large intestines without definite transition point identified. pt was kept npo and ng tube was placed to low-intermittent suction with improvement in patient's emesis and pain. dilaudid and fentanyl patch also improved patient's pain. pt's emesis resolved completely. pt developed diarrhea as well, this was c diff negative x3. by discharge, her emesis had stopped, and she was started on clear liquid diet with mild nausea. the ng tube was left in place in the event of recurrent emesis. . metastatic ovarian cancer: extensive pulmonary mets as well as abdominal disease seen on ct torso, pt and family was made aware of this metastasis. benefit from systemic chemotherapy. she requested transfer back to for management per her primary oncologist. . aspiration pna: concern for aspiration pna given aspiration event, leukocytosis, and tachycardia. cefepime and metronidazole were added to linezolid and pt improved significantly. sputum cx nondiagnostic and blood cx remained negative. she will need an 8 day course of linezolid, flagyl and cefepime (last dose ) uti: per osh results, sig for 100,000 vanc resistent enterococcus (vre). continued linezolid. urine culture here was negative. . diarhea: she developed significant diarrhea, requiring rectal tube. stool was negative for c diff x 3. . nsvt: pt developed significant nsvt, probably beta blocker withdrawal and hypokalemia diarrhea/emesis. repleted k and started metoprolol 5mg iv q4h to good effect. she was transitioned to po metoprolol 25 mg po tid on the day of discharge, which can be titrated up as necessary. htn: restarted betablocker as above . hyperlipidemia: holding statin . fen: on clear liquid diets as of today, replete electrolytes, regular diet -- if cannot start tolerating pos soon will need nutrition consult for possible tpn . prophylaxis: subutaneous heparin . access: peripherals . code: full . communication: patient . disposition: transfer back to hospital today medications on admission: transfer medications: linezolid 600mg lopressor 50mg daily pantoprazole 40mg paxil 20mg daily simethicone 80mg tid simvastatin 40mg daily sucralfate 1gm letrozole 2.5g daily lovenox 40mg daily discharge medications: 1. heparin (porcine) 5,000 unit/ml solution sig: one (1) injection tid (3 times a day). 2. fentanyl 25 mcg/hr patch 72 hr sig: one (1) patch 72 hr transdermal q72h (every 72 hours). 3. sucralfate 1 gram tablet sig: one (1) tablet po qid (4 times a day). 4. linezolid 600 mg iv q12h 5. pantoprazole 40 mg iv q12h 6. ondansetron 4 mg iv q8h:prn nausea 7. prochlorperazine 10 mg iv q6h:prn nausea 8. metronidazole (flagyl) 500 mg iv q8h 9. cefepime 1 g iv q12h 10. hydromorphone (dilaudid) 0.5 mg iv q2h:prn pain hold for sedation or rr<12 11. potassium chloride 40 meq / 100 ml sw iv once duration: 1 doses 12. calcium gluconate 2 g iv once duration: 1 doses 13. magnesium sulfate 2 gm iv once duration: 1 doses 14. metoprolol tartrate 5 mg iv q4h hold for sbp <100, hr <55 15. heparin flush (10 units/ml) 2 ml iv prn line flush picc, heparin dependent: flush with 10ml normal saline followed by heparin as above daily and prn per lumen. 16. sodium chloride 0.9% flush 3 ml iv q8h:prn line flush peripheral line: flush with 3 ml normal saline every 8 hours and prn. discharge disposition: extended care discharge diagnosis: primary: cholecystitis small bowel obstruction aspiration pneumonia discharge condition: mental status:clear and coherent level of consciousness:alert and interactive activity status:out of bed with assistance to chair or wheelchair. ng tube in place, not to suction. foley catheter in place. vre precautions. picc in place. discharge instructions: you were transferred to for ercp. we found a mass compressing the biliary tree. you had a stent placed to relieve obstruction. you were also vomiting, because of a small bowel obstruction. we treated you for an aspiration pneumonia and placed an nasogastric tube for your obstruction. we are transferring you to for further managment based on your request. followup instructions: you are being transfered to for further management. . follow up with your primary oncologist and primary care doctor after discharge. procedure: venous catheterization, not elsewhere classified endoscopic sphincterotomy and papillotomy endoscopic insertion of stent (tube) into bile duct injection or infusion of oxazolidinone class of antibiotics diagnoses: urinary tract infection, site not specified unspecified essential hypertension other specified intestinal obstruction hypopotassemia other and unspecified hyperlipidemia pneumonitis due to inhalation of food or vomitus other respiratory complications diarrhea secondary malignant neoplasm of lung accidents occurring in residential institution obstruction of bile duct secondary malignant neoplasm of retroperitoneum and peritoneum other restorative surgery causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation cholecystitis, unspecified personal history of malignant neoplasm of ovary malignant ascites 

Answer: The patient is high likely exposed to